atezolizumab,tiragolumab
roche
['atezo', 'tiragolumab']
#asco22 forest plot does not identify any subgroups showing benefit with tiragolumab here. the backbone of carboplatin, etoposide, and atezolizumab performs well in pts with brain metastases, including untreated disease. no meaningful difference in rr. no concerning safety signal 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him